Literature DB >> 2539265

Interleukins 1 and 2 production and responsiveness in the early stages of retroviral infections of mice.

D Matteucci1, A M Giangregorio, M Lopez-Cepero, S Specter, M Bendinelli, H Friedman.   

Abstract

Infection of BALB/c mice with the Friend leukemia complex (FLC) or its helper F-MuLV produced no major changes of IL 1 production and responsiveness but caused profound derangements of IL 2 homeostasis. IL 2 production by spleen cells was severely decreased from the early stages postinfection (pi). By Day 8 the effects of the two viral preparations were similar. Reminiscent of the kinetics of immunosuppression produced by the two viruses, subsequently the effects diverged: in the case of FLC, IL 2 accumulation became progressively lower, while F-MuLV-infected spleen cells produced approximately half the normal levels of IL 2 irrespective of time pi. At Day 8 pi unstimulated spleen cells absorbed enhanced amounts of IL 2, but failed to proliferate in response to it. Unfractionated and adherent spleen cells from infected mice (but not cell-free virus or culture fluids) inhibited the proliferative response of CTLL-2 cells to IL 2, suggesting a "suppressor" function for infected macrophages. Exogenous IL 2 failed to bring in vitro antigen or mitogen responsiveness of infected spleen cells to the levels seen with control cells and did not affect FLC-induced leukemogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539265     DOI: 10.1016/0008-8749(89)90170-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Effect of Friend leukemia virus infection on susceptibility to Candida albicans.

Authors:  M A Moors; S M Jones; K K Klyczek; T J Rogers; H R Buckley; K J Blank
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Lipopolysaccharide restores anti-Candida albicans growth inhibition activity of polymorphonuclear neutrophils from retrovirus-immunosuppressed mice.

Authors:  Y Yamamoto; S Specter; H Friedman
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.